Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma. - Archive ouverte HAL Access content directly
Journal Articles Clinical Biochemistry Year : 2009

Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.

(1, 2) , (3) , (4) , (5) , (4, 6) , (7) , (8) , (1) , (1, 3)
1
2
3
4
5
6
7
8

Abstract

We assessed comparatively the diagnostic value of two potential malignant pleural mesothelioma (MPM) markers: hyaluronic acid (HA) and soluble mesothelin. MATERIALS AND METHOD: We measured serum and pleural fluid values of mesothelin and hyaluronic acid in 76 patients with MPM, 33 patients with pleural metastases of carcinomas (Mets group) and 27 patients with benign pleural effusion related to asbestos exposure (BPLAE). RESULTS: Using a serum HA cut-off of 100 microg/L, 8 patients/33 (24.2%) were positive in the Mets group versus 20/76 (26.3%) in the MPM group and only 1/27 BPLAE patients. The area under ROC curve for serum HA in MPM versus Mets or BPLAE groups was only 0.617 while it was 0.755 for mesothelin. In pleural fluid, both markers had similar diagnostic values. CONCLUSIONS: Serum mesothelin is more sensitive than hyaluronic acid in diagnosing MPM and there is no benefit in combining both markers.
Fichier principal
Vignette du fichier
Acyde_hyaluronique_mesothelioma.pdf (90.16 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-00407520 , version 1 (25-07-2009)

Identifiers

Cite

Bogdan Dragos Grigoriu, Bachar Chahine, Farid Zerimech, Marc Grégoire, Malika Balduyck, et al.. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.. Clinical Biochemistry, 2009, 42 (10-11), pp.1046-50. ⟨10.1016/j.clinbiochem.2009.03.007⟩. ⟨inserm-00407520⟩
223 View
563 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More